(3''aS,4''R,5''R,6''aR)-Hexahydro-5''-hydroxy-5,5-dimethyl-spiro[1,3-dioxane-2,2''(1''H)-pentalene]-4''-carboxylic Acid Methyl Ester

(3''aS,4''R,5''R,6''aR)-Hexahydro-5''-hydroxy-5,5-dimethyl-spiro[1,3-dioxane-2,2''(1''H)-pentalene]-4''-carboxylic Acid Methyl Ester 구조식 이미지
카스 번호:
118375-00-1
상품명:
(3''aS,4''R,5''R,6''aR)-Hexahydro-5''-hydroxy-5,5-dimethyl-spiro[1,3-dioxane-2,2''(1''H)-pentalene]-4''-carboxylic Acid Methyl Ester
동의어(영문):
Iloprost Impurity 9;Spiro[1,3-dioxane-2,2'(1'H)-pentalene]-4'-carboxylic acid, hexahydro-5'-hydroxy-5,5-dimethyl-, methyl ester, (3'aS,4'R,5'R,6'aR)-;(3''aS,4''R,5''R,6''aR)-Hexahydro-5''-hydroxy-5,5-dimethyl-spiro[1,3-dioxane-2,2''(1''H)-pentalene]-4''-carboxylic Acid Methyl Ester
CBNumber:
CB95988913
분자식:
C15H24O5
포뮬러 무게:
284.35
MOL 파일:
118375-00-1.mol

(3''aS,4''R,5''R,6''aR)-Hexahydro-5''-hydroxy-5,5-dimethyl-spiro[1,3-dioxane-2,2''(1''H)-pentalene]-4''-carboxylic Acid Methyl Ester 속성

끓는 점
389.2±42.0 °C(Predicted)
밀도
1.20±0.1 g/cm3(Predicted)
용해도
클로로포름, 에틸아세테이트, 메탄올에 용해됨
물리적 상태
기름
산도 계수 (pKa)
14.47±0.60(Predicted)
색상
투명한

안전

(3''aS,4''R,5''R,6''aR)-Hexahydro-5''-hydroxy-5,5-dimethyl-spiro[1,3-dioxane-2,2''(1''H)-pentalene]-4''-carboxylic Acid Methyl Ester C화학적 특성, 용도, 생산

용도

(3''aS,4''R,5''R,6''aR)-Hexahydro-5''-hydroxy-5,5-dimethyl-spiro[1,3-dioxane-2,2''(1''H)-pentalene]-4''-carboxylic Acid Methyl Ester is an intermediate in the synthesis of Iloprost (I267300),a synthetic analogue of Prostacyclin (PGI2) used to treat pulmonary arterial hypertension (PAH), scleroderma, raynaud''s phenomenon and ischemia.

(3''aS,4''R,5''R,6''aR)-Hexahydro-5''-hydroxy-5,5-dimethyl-spiro[1,3-dioxane-2,2''(1''H)-pentalene]-4''-carboxylic Acid Methyl Ester 준비 용품 및 원자재

원자재

준비 용품


(3''aS,4''R,5''R,6''aR)-Hexahydro-5''-hydroxy-5,5-dimethyl-spiro[1,3-dioxane-2,2''(1''H)-pentalene]-4''-carboxylic Acid Methyl Ester 공급 업체

글로벌( 4)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016; 18162595016
3287908757@qq.com China 9117 58

Copyright 2019 © ChemicalBook. All rights reserved